Skip to main content

Table 1 Characteristics of the participants enrolled in the study

From: Possible role of plasma Galectin-9 levels as a surrogate marker of viremia in HIV infected patients on antiretroviral therapy in resource-limited settings

Groups median (range)

Immunologic non responders (n = 23)

Matched responders (n = 40)

Treatment failure (n = 18)

Virologic non responders (n = 25)

P value viremic vs aviremic

Age: years

42 (23–60)

39.5 (25–62)

37.5 (24–52)

35 (18–55)

0.016

Baseline CD4: cells/cmm

270 (14–380)

283.5 (25–352)

142.5 (8–358)

159 (22–350)

< 0.0001

Enrolment CD4: cells/cmm

227 (13–360)

479 (246–1387)

89 (19–331)

317 (99–809)

< 0.0001

Viral load (copies/ml)

< 40

< 40

63,165 (1891–526,175)

12,366 (1056–889,079)

< 0.0001